Post-approval studies (Phase 4)Study completedNCT03143101
What this trial is testing
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
Who this might be right for
InfluenzaHealthy
MedImmune LLC 200